Concepedia

Shirley Pullan

SP

Statistics

Publications

8

Citations

521

H-Index

8

Active since

1996

Affiliations

Johnson & Johnson (United States)(Current)

Shirley Pullan is an author at Johnson & Johnson (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1996–2009

8

Publications

8

Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium

Shirley Pullan, James W. Wilson, Anthony D. Metcalfe et al. · Journal of Cell Science · 1996 · 302 citations

JNJ-20788560 [9-(8-Azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic Acid Diethylamide], a Selective Delta Opioid Receptor Agonist, Is a Potent and Efficacious Antihyperalgesic Agent That Does Not Produce Respiratory Depression, Pharmacologic Tolerance, or Physical Dependence

Ellen E. Codd, John R. Carson, Raymond W. Colburn et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 67 citations

In vivo imaging of human colon cancer xenografts in immunodeficient mice using a guanylyl cyclase C--specific ligand.

Henry R. Wolfe, Marivi Mendizabal, Elinor Lleong et al. · PubMed · 2002 · 53 citations

, , +19

The mammary gland epithelial cell

Shirley Pullan, Charles Streuli · 1996 · 27 citations

, , +7

Gene expression profiles highlight adaptive brain mechanisms in corticotropin releasing factor overexpressing mice

Pieter J. Peeters, Frederik Fierens, Ilse Van den Wyngaert et al. · Molecular Brain Research · 2004 · 24 citations

, , +10

Rows per page

1–5 of 8